Carbaglu (carglumic acid) is a small molecule pharmaceutical. Carglumic acid was first approved as Carbaglu on 2003-01-24. It is used to treat hyperammonemia in the USA. It has been approved in Europe to treat hyperammonemia, inborn errors amino acid metabolism, and propionic acidemia.
|Common Name||Carglumic acid|
|Indication||hyperammonemia, inborn errors amino acid metabolism, propionic acidemia|